RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets
about
Brief History and Characterization of Enhanced Respiratory Syncytial Virus DiseaseRespiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced DiseasesProteomic contributions to our understanding of vaccine and immune responses.Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology.Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus.Novel therapies and vaccines against the human respiratory syncytial virus.Fc receptors in antibody-dependent enhancement of viral infections.Recent advances in the development of subunit-based RSV vaccines.Approaches to Evaluate Lung Inflammation in Translational Research.New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants.Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies.Animal models of respiratory syncytial virus infection.The Human Immune Response to Respiratory Syncytial Virus Infection.Ongoing developments in RSV prophylaxis: a clinician's analysis.Virus vs. virus: adenovirus vectored vaccine to defeat respiratory syncytial virus.Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection.A Built-In CpG Adjuvant in RSV F Protein DNA Vaccine Drives a Th1 Polarized and Enhanced Protective Immune Response.Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus.
P2860
Q26775152-87663C30-B6D3-4091-AB32-CD5BB6DD6484Q30240274-1B414138-76D0-4F7F-A22D-5D46D9CD300AQ36246429-F854631A-DC86-4383-98E3-9C1F0EE5D82BQ36464016-13BA6A0A-4C25-4FC0-A735-17346C24C464Q37197103-EEF6AFDD-EA56-42DF-857D-45C3C0133F7BQ37293748-55E27CAF-9A79-4903-94A8-7A5909F9C8F3Q38604787-5795F595-BD84-44F9-BB92-A4CEC771982DQ38615396-DB11CE2A-F967-449A-8A01-235A39606D3AQ38617302-2985DBF2-F29A-4011-842A-78EC324A57E0Q38622502-9CBF2A43-9428-4BFE-A711-7C9424A1D0F6Q38628928-39778F91-7867-452D-83EB-3A79CC65A006Q38631747-3D0F643F-BAE4-4097-9E55-34FCB9C68A06Q39007664-463B3C69-C989-4177-BBAE-BC51B41DAA33Q39026362-BED9C981-7539-44EE-B893-A19A01C6E84AQ39127064-B9AF4F9A-B0CD-43F5-9C3D-DC94D22E60AFQ39303791-5D01C91D-872C-4C5D-81B0-9CB9801FD423Q42330836-E02C7F34-4042-4D00-8D24-B6BA2FC50B1CQ47238680-1F6F005F-3CE4-4FFA-8087-F36E4C99E334Q47552388-4BF52568-A586-4474-AF87-324D34A6D834Q52649839-93301BE3-ABCA-4EA0-9704-B9AF16C32E0F
P2860
RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
RSV vaccine-enhanced disease i ...... of distinct CD4 T cell subsets
@ast
RSV vaccine-enhanced disease i ...... of distinct CD4 T cell subsets
@en
type
label
RSV vaccine-enhanced disease i ...... of distinct CD4 T cell subsets
@ast
RSV vaccine-enhanced disease i ...... of distinct CD4 T cell subsets
@en
prefLabel
RSV vaccine-enhanced disease i ...... of distinct CD4 T cell subsets
@ast
RSV vaccine-enhanced disease i ...... of distinct CD4 T cell subsets
@en
P2860
P1433
P1476
RSV vaccine-enhanced disease i ...... of distinct CD4 T cell subsets
@en
P2093
Cory J Knudson
Stacey M Hartwig
P2860
P304
P356
10.1371/JOURNAL.PPAT.1004757
P577
2015-03-13T00:00:00Z